Further work revealed that Nrg4-ADSC could enhance this beneficial effect by reducing liver lipogenesis, whereas ADSC did not demonstrate this effect, suggesting that the mechanism by which Nrg4 improves IR can be achieved in part by limiting liver steatosis (Wang et al., 2019a). Here, NRG4 is linked to fatty liver disease.